Quick Answer
RxSight, Inc. reported Common Stock Shares Outstanding of 41.24 million shares for the year ending 2025.
- RxSight, Inc. showed an increase of +2.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from RxSight, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: 4.12 million shares | Q3 2021: 27.32 million shares | Q1 2022: 27.49 million shares | Q2 2022: 27.63 million shares | Q3 2022: 27.72 million shares | Q1 2023: 33.97 million shares | Q2 2023: 35.17 million shares | Q3 2023: 35.85 million shares | Q1 2024: 37.16 million shares | Q2 2024: 39.62 million shares | Q3 2024: 40.25 million shares | Q1 2025: 40.59 million shares | Q2 2025: 40.91 million shares | Q3 2025: 41.08 million shares.
- Over the full 5 years of available data (2021 to 2025), RxSight, Inc.'s Common Stock Shares Outstanding has grown by 50.7%.
- Historical annual values: Fiscal year 2025: 41.24 million shares | Fiscal year 2024: 40.43 million shares | Fiscal year 2023: 36.14 million shares | Fiscal year 2022: 28.27 million shares | Fiscal year 2021: 27.37 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: